Compare LND & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LND | CYRX |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | Brazil | United States |
| Employees | N/A | 1100 |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.6M | 419.3M |
| IPO Year | N/A | 2008 |
| Metric | LND | CYRX |
|---|---|---|
| Price | $3.81 | $13.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 77.2K | ★ 662.7K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $1.65 | $11.06 |
| Revenue Next Year | $6.42 | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.47 | $5.31 |
| 52 Week High | $4.45 | $14.36 |
| Indicator | LND | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 71.94 |
| Support Level | $3.77 | $7.98 |
| Resistance Level | $4.29 | N/A |
| Average True Range (ATR) | 0.09 | 0.75 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 46.55 | 89.05 |
Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.